Vaccine Logistics Market Size (2024 - 2029)

The Vaccine Logistics Market is experiencing growth driven by the increasing demand for vaccine storage and transportation services, particularly due to the COVID-19 pandemic. This expansion is influenced by the need for enhanced cold-chain infrastructure, which is essential for accommodating the diverse range of new vaccines and immunization schedules. Despite the challenges posed by insufficient funding and the evolving landscape of immunization programs, the market is poised for growth, with pharmaceutical companies investing in cold chain logistics to meet rising demands.

Home Market Analysis Logistics Research Customers of Logistics Services Research Healthcare Logistics Research Pharma Logistics Research Vaccine Logistics Market Market Size

Market Size of Vaccine Logistics Industry

Vaccine Logistics Market Summary
Study Period 2020 - 2029
Market Size (2024) USD 3.13 Billion
Market Size (2029) USD 4.04 Billion
CAGR (2024 - 2029) 5.20 %
Fastest Growing Market Asia-Pacific
Largest Market Europe

Major Players

Vaccine Logistics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Vaccine Logistics Market Analysis

The Vaccine Logistics Market size is estimated at USD 3.13 billion in 2024, and is expected to reach USD 4.04 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029).

The wide variety of new vaccines and immunization schedules and service delivery strategies, the expanding target population, the increased cold-chain infrastructure requirements, and insufficient funding are some of the new realities that may further impact the vaccine transportation market.

The existing systems are struggling to keep pace with the changing landscape of national and international immunization programs, especially after the development of the COVID-19 vaccine, resulting in stock-outs, avoidable wastage, and inadequate cold-chain capacity. All the aforementioned factors have considerable coverage, performance, and cost implications.

Due to the enormous rise in demand for vaccine storage services brought on by the COVID-19 epidemic, pharmaceutical companies focused their efforts on creating cold chain logistics. Therefore, the vaccine cold chain logistics market will probably see new growth prospects in the coming years due to the increasing R&D initiatives.

Vaccine Logistics Industry Segmentation

Vaccines are widely used as one of the prevention strategies to control infectious diseases. The study on global vaccine transportation covers an analysis of the logistics and storage facilities dedicated to the transportation of vaccines around the world.

The report also covers an assessment of the global economy, emerging trends by segments and regional markets, significant changes in market dynamics, and a market overview. The report also covers the impact of COVID-19 on the market.

The vaccine logistics market is segmented by service (transportation, warehousing, and value-added services (packaging, labeling, etc.), end user (hospitals, drug manufacturers and distributors, and other end users (blood banks, clinics, etc.)), and geography (Asia-Pacific, Europe, North America, South America, and the Middle East). The report offers market size and forecasts in value (USD) for all the above segments.

By Service
Transportation
Land (Road and Rail)
Air
Sea
Warehousing
Value-added Services (Packaging, Labeling, etc.)
By End User
Hospitals
Drug Manufacturers and Distributors
Other End Users (Blood Banks, Clinics, etc.)
By Geography
Asia-Pacific
China
Japan
Australia
India
Singapore
Malaysia
Indonesia
Thailand
South Korea
Rest of Asia-Pacific
Europe
Germany
France
United Kingdom
Italy
Rest of Europe
North America
United States
Canada
Mexico
South America
Brazil
Colombia
Argentina
Rest of South America
Middle East
Egypt
Qatar
Saudi Arabia
United Arab Emirates
Rest of the Middle East
Need A Different Region Or Segment?
Customize Now

Vaccine Logistics Market Size Summary

The vaccine logistics market is poised for significant growth, driven by the evolving landscape of global immunization programs and the increasing demand for temperature-controlled transportation and storage solutions. The market is experiencing a transformation due to the development of new vaccines and immunization strategies, coupled with the expanding target population. The COVID-19 pandemic has further accelerated the need for robust cold chain logistics, as pharmaceutical companies have intensified their focus on ensuring the safe and efficient distribution of vaccines. This has led to the adoption of advanced technologies such as RFID and IIoT to enhance the efficiency of cold chain operations. The market is characterized by a fragmented landscape, with major international players like Yamato, Deutsche Post DHL Group, and Nippon Express leading the charge through strategic acquisitions and expansions.

The demand for pharmaceutical logistics is expected to rise globally, supported by government initiatives and the growing importance of fast-track assistance in the healthcare sector. The development of high-tech containers and refrigerated trucks with multi-segment temperature capabilities is gaining traction, addressing the challenges of maintaining the integrity of temperature-sensitive goods during transportation. The market's growth is further bolstered by the increasing need for effective cold chain logistics services to uphold product quality, particularly in the pharmaceutical industry, where complex biological-based medicines require meticulous handling. As the global pharmaceuticals industry continues to expand, the sub-category of temperature-controlled products is witnessing a surge, creating new opportunities for market players to enhance their reach and operational efficiency.

Explore More

Vaccine Logistics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS AND INSIGHTS

    1. 1.1 Current Market Scenario

    2. 1.2 Market Dynamics

      1. 1.2.1 Drivers

        1. 1.2.1.1 technology innovation in temperature controlled packaging

        2. 1.2.1.2 Cross Border collaborations and initiative to enhance healthcare infrastructure

      2. 1.2.2 Restraints

        1. 1.2.2.1 Supply chain distruption and transportation bottlenecks can hinder timely vaccine distribution

      3. 1.2.3 Opportunities

        1. 1.2.3.1 Adoption of blockchain and IoT technology can improve transparency and tracebility

    3. 1.3 Technological Trends and Automation

    4. 1.4 Government Regulations and Initiatives

    5. 1.5 Industry Value Chain/Supply Chain Analysis

    6. 1.6 Spotlight on Ambient/Temperature-controlled Storage

    7. 1.7 Industry Attractiveness - Porter's Five Forces Analysis

    8. 1.8 Impact of COVID-19 on the Market

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Service

      1. 2.1.1 Transportation

        1. 2.1.1.1 Land (Road and Rail)

        2. 2.1.1.2 Air

        3. 2.1.1.3 Sea

      2. 2.1.2 Warehousing

      3. 2.1.3 Value-added Services (Packaging, Labeling, etc.)

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Drug Manufacturers and Distributors

      3. 2.2.3 Other End Users (Blood Banks, Clinics, etc.)

    3. 2.3 By Geography

      1. 2.3.1 Asia-Pacific

        1. 2.3.1.1 China

        2. 2.3.1.2 Japan

        3. 2.3.1.3 Australia

        4. 2.3.1.4 India

        5. 2.3.1.5 Singapore

        6. 2.3.1.6 Malaysia

        7. 2.3.1.7 Indonesia

        8. 2.3.1.8 Thailand

        9. 2.3.1.9 South Korea

        10. 2.3.1.10 Rest of Asia-Pacific

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 France

        3. 2.3.2.3 United Kingdom

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Rest of Europe

      3. 2.3.3 North America

        1. 2.3.3.1 United States

        2. 2.3.3.2 Canada

        3. 2.3.3.3 Mexico

      4. 2.3.4 South America

        1. 2.3.4.1 Brazil

        2. 2.3.4.2 Colombia

        3. 2.3.4.3 Argentina

        4. 2.3.4.4 Rest of South America

      5. 2.3.5 Middle East

        1. 2.3.5.1 Egypt

        2. 2.3.5.2 Qatar

        3. 2.3.5.3 Saudi Arabia

        4. 2.3.5.4 United Arab Emirates

        5. 2.3.5.5 Rest of the Middle East

Vaccine Logistics Market Size FAQs

The Vaccine Logistics Market size is expected to reach USD 3.13 billion in 2024 and grow at a CAGR of 5.20% to reach USD 4.04 billion by 2029.

In 2024, the Vaccine Logistics Market size is expected to reach USD 3.13 billion.

Vaccine Logistics Market Report Snapshots

Vaccine Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)